PMDA drug package insert
MSツワイスロンカプセル10mg
PMDA Prescription drug · 帝國製薬株式会社 · package insert Nov 14, 2024
Key facts
| Brand names | MSツワイスロンカプセル10mg, MSツワイスロンカプセル30mg, MSツワイスロンカプセル60mg |
|---|---|
| Nonproprietary names | モルヒネ硫酸塩水和物 |
| Companies | 製造販売元／帝國製薬株式会社, 提携／エチファーム社 |
| Product type | Prescription drug |
| Therapeutic category | 持続性がん疼痛治療剤 |
| Therapeutic category codes | 878114 |
| YJ codes | 8114004N4025, 8114004N5021, 8114004N6028 |
| Approval numbers | 21300AMZ00348, 21300AMZ00347, 21300AMZ00349 |
| Package insert edition | 第3版 |
| Package insert date | Nov 14, 2024 |
| PMDA document key | 470006_8114004N4025_2 |
| PMDA company code | 470006 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: